LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells
Authors
Keywords
-
Journal
Oncogenesis
Volume 8, Issue 11, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-16
DOI
10.1038/s41389-019-0170-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
- (2019) Dong-ming Wu et al. Cell Death & Disease
- Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis
- (2019) Na Yao et al. ONCOGENE
- Long noncoding RNAs in cancer cells
- (2018) Duc-Hiep Bach et al. CANCER LETTERS
- PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα
- (2018) Higinio Dopeso et al. CANCER RESEARCH
- Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment
- (2018) Zhenqiang Sun et al. Molecular Cancer
- HOXB7 overexpression in lung cancer is a hallmark of acquired stem-like phenotype
- (2018) Simona Monterisi et al. ONCOGENE
- Long Noncoding RNA in Cancer: Wiring Signaling Circuitry
- (2018) Chunru Lin et al. TRENDS IN CELL BIOLOGY
- HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway
- (2017) Xianxiang Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
- (2017) Yuanyuan Lu et al. NATURE MEDICINE
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- LncRNA-mediated regulation of cell signaling in cancer
- (2017) W-X Peng et al. ONCOGENE
- Temporal and spatial requirements for Hoxa3 in mouse embryonic development
- (2016) Jena L. Chojnowski et al. DEVELOPMENTAL BIOLOGY
- Long non-coding RNAs in cancer drug resistance development
- (2016) Maryam Majidinia et al. DNA REPAIR
- Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis
- (2016) Hao Sun et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Enforced Expression of Hoxa3 Inhibits Classical and Promotes Alternative Activation of Macrophages In Vitro and In Vivo
- (2016) Hadeel Al Sadoun et al. JOURNAL OF IMMUNOLOGY
- Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis
- (2016) Chunyang Jiang et al. Molecular Cancer
- Epithelial–mesenchymal transition: a new target in anticancer drug discovery
- (2016) Fabrizio Marcucci et al. NATURE REVIEWS DRUG DISCOVERY
- NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma
- (2016) Shuang Lin et al. ONCOLOGY REPORTS
- Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
- (2016) Julia Beermann et al. PHYSIOLOGICAL REVIEWS
- Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells
- (2016) Xin-Xing Zhu et al. Oncotarget
- Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma
- (2016) Iben Daugaard et al. Scientific Reports
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- Multiple roles for HOXA3 in regulating thymus and parathyroid differentiation and morphogenesis in mouse
- (2014) J. L. Chojnowski et al. DEVELOPMENT
- Development of oculomotor circuitry independent of hox3 genes
- (2014) Leung-Hang Ma et al. Nature Communications
- DNA Based Therapy with Diphtheria Toxin-A BC-819: A Phase 2b Marker Lesion Trial in Patients with Intermediate Risk Nonmuscle Invasive Bladder Cancer
- (2013) Ofer N. Gofrit et al. JOURNAL OF UROLOGY
- Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer
- (2012) N Hanna et al. CANCER GENE THERAPY
- Aerosolized BC-819 Inhibits Primary but Not Secondary Lung Cancer Growth
- (2011) Günther Hasenpusch et al. PLoS One
- Hoxa3 promotes the differentiation of hematopoietic progenitor cells into proangiogenic Gr-1+CD11b+ myeloid cells
- (2010) E. Mahdipour et al. BLOOD
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
- Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
- (2009) Aya Mizrahi et al. Journal of Translational Medicine
- HOXA3 Modulates Injury-Induced Mobilization and Recruitment of Bone Marrow-Derived Cells
- (2009) Kimberly A. Mace et al. STEM CELLS
- Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin
- (2008) Abraham Ami Sidi et al. JOURNAL OF UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More